Cargando…

Angiogenesis in the corpus luteum

The corpus luteum (CL) is a site of intense angiogenesis. Within a short period, this is followed either by controlled regression of the microvascular tree in the non-fertile cycle, or maintenance and stabilisation of the new vasculature a conceptual cycle. The molecular regulation of these diverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraser, Hamish M, Wulff, Christine
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC305342/
https://www.ncbi.nlm.nih.gov/pubmed/14613536
http://dx.doi.org/10.1186/1477-7827-1-88
_version_ 1782121097542500352
author Fraser, Hamish M
Wulff, Christine
author_facet Fraser, Hamish M
Wulff, Christine
author_sort Fraser, Hamish M
collection PubMed
description The corpus luteum (CL) is a site of intense angiogenesis. Within a short period, this is followed either by controlled regression of the microvascular tree in the non-fertile cycle, or maintenance and stabilisation of the new vasculature a conceptual cycle. The molecular regulation of these diverse aspects is examined. The CL provides a unique model system in which to study the cellular and molecular regulation of angiogenesis. Vascular endothelial growth factor (VEGF) has been found to have a major role in the CL. By targeting its action at specific stages of the luteal phase in vivo by antagonists, profound inhibitory effects on luteal angiogenesis and function are observed.
format Text
id pubmed-305342
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-3053422004-01-01 Angiogenesis in the corpus luteum Fraser, Hamish M Wulff, Christine Reprod Biol Endocrinol Review The corpus luteum (CL) is a site of intense angiogenesis. Within a short period, this is followed either by controlled regression of the microvascular tree in the non-fertile cycle, or maintenance and stabilisation of the new vasculature a conceptual cycle. The molecular regulation of these diverse aspects is examined. The CL provides a unique model system in which to study the cellular and molecular regulation of angiogenesis. Vascular endothelial growth factor (VEGF) has been found to have a major role in the CL. By targeting its action at specific stages of the luteal phase in vivo by antagonists, profound inhibitory effects on luteal angiogenesis and function are observed. BioMed Central 2003-11-10 /pmc/articles/PMC305342/ /pubmed/14613536 http://dx.doi.org/10.1186/1477-7827-1-88 Text en Copyright © 2003 Fraser and Wulff; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Review
Fraser, Hamish M
Wulff, Christine
Angiogenesis in the corpus luteum
title Angiogenesis in the corpus luteum
title_full Angiogenesis in the corpus luteum
title_fullStr Angiogenesis in the corpus luteum
title_full_unstemmed Angiogenesis in the corpus luteum
title_short Angiogenesis in the corpus luteum
title_sort angiogenesis in the corpus luteum
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC305342/
https://www.ncbi.nlm.nih.gov/pubmed/14613536
http://dx.doi.org/10.1186/1477-7827-1-88
work_keys_str_mv AT fraserhamishm angiogenesisinthecorpusluteum
AT wulffchristine angiogenesisinthecorpusluteum